Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us

  • Exchange: New York
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Specialty Pharma

Valeant Pharmaceuticals International Inc

+ Add to Watchlist

VRX:US

210.4200 USD 1.0300 0.49%

As of 20:04:02 ET on 04/24/2015.

Company Profile for Valeant Pharmaceuticals International Inc (VRX)

Valeant Pharmaceuticals International, Inc. develops and distributes drugs. The Company develops drugs for unmet medical needs in central nervous system disorders, and distributes generic and branded generic drugs in Latin America and Eastern Europe.

Contact Information

Valeant Pharmaceuticals International Inc

400 Somerset Corporate Bouleva
Bridgewater, NJ 08807
United States
Phone: 1-908-927-1400

Key Executives for Valeant Pharmaceuticals International Inc (VRX)

J Michael Pearson "Mike"Chairman/CEOAri S KellenGroup Chairman/Exec VP
Laizer D KornwasserGroup Chairman/Exec VPPavel MirovskyPresident/Gen Mgr:Europe
Howard B SchillerExec VP/CFORobert R Chai-OnnExec VP/Chief Legal Ofcr/Gen Cnsl
Brian M StolzExec VP:AdministrationLinda A LagorgaSenior VP/Treasurer
Laurie W LittleVP:Investor Relations

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Advertisements
Advertisement
sec ||= nil